Institutional Career Development Core (Chapter 1)

机构职业发展核心（第一章）

• 批准号: 9528026
• 负责人: ERIC C BEYER
• 金额: $ 63.23万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-06 至 2022-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9528026
• 关键词: Clinical; Clinical Research; Communication; Communities; Competence; Disease; Doctor of Philosophy; Entrepreneurship; Faculty; Goals; Individual; Investigation; K-Series Research Career Programs; Leadership; Mentored Clinical Scientist Development Program; Mentorship; Nurses; Physicians; Program Development; Research; Research Personnel; Scientist; Surgeon; Time; Training; Translational Research; career development; human disease; improved; instructor; member; multidisciplinary; next generation; patient population; professor; programs; tool; translational scientist

The goal of the ITM CTSA KL2 Scholar mechanism is to produce faculty researchers who can utilize the tools of clinical and translational research to improve the understanding or treatment of human disease. The program will include 4 KL2 Scholars at any time. We anticipate supporting 2 years of multidisciplinary training for each selected Scholar, who will devote ≥75% effort to investigation and training (≥50% for surgeons). Scholars must be full time faculty members (typically Assistant Professors or Instructors), but may be physician-scientists, nurse-scientists, or PhD investigators. Research topics can relate to any aspect of clinical and/or translational research and to any patient population or disease group. Any suitable research approach can be employed. However, relevance to the understanding or treatment of human disease must be demonstrated. All Scholars will have multidisciplinary mentorship teams containing multiple members, and will acquire all requisite competencies. The impact of the CTSA KL2 program will be amplified through a “K Community” including K Scholars in three other K12 programs and numerous individual Career Development award recipients. The ITM will support many aspects of scholar career development including training in grantsmanship, communications, mentorship, leadership, teamwork, and entrepreneurship. In this way, the ITM KL2 Career Development Program will help build the next generation of clinical and translational scientists.

ITM CTSA KL2 学者机制的目标是培养能够利用这些工具的教师研究人员 旨在提高对人类疾病的理解或治疗的临床和转化研究。这 计划将随时包括 4 名 KL2 学者。我们预计支持 2 年的多学科培训 对于每位选定的学者，他们将投入≥75%的精力用于调查和培训（外科医生≥50%）。 学者必须是全职教员（通常是助理教授或讲师），但也可以是 医师科学家、护士科学家或博士研究员。研究主题可以涉及临床的任何方面 和/或转化研究以及任何患者群体或疾病组。任何合适的研究方法 可以就业。然而，与理解或治疗人类疾病的相关性必须是 证明了。所有学者都将拥有由多名成员组成的多学科导师团队，并将 获得所有必要的能力。 CTSA KL2 计划的影响将通过“K 社区”，包括其他三个 K12 项目的 K 学者和众多个人职业发展 获奖者。 ITM 将支持学者职业发展的许多方面，包括培训 资助、沟通、指导、领导力、团队合作和创业精神。这样， ITM KL2 职业发展计划将帮助建立下一代临床和转化 科学家。